What is the Forecast Price for Canopy Growth Corp (CGC) Stock?

Thursday, September 10, 2020 2:19 PM | InvestorsObserver Analysts

InvestorsObserver is giving Canopy Growth Corp (CGC) an Analyst Rating Rank of 16, meaning CGC is ranked higher by analysts than 16% of stocks. The average projection by analysts for CGC is $19.716 over the next 12 months and analyst’s classify the stock as a Buy

Overall Score - 3.2
Wall Street analysts are rating CGC a Buy today. Find out what this means to you and get the rest of the rankings on CGC!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.

Investors Observer averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Canopy Growth Corp Stock Today?

Canopy Growth Corp (CGC) stock is up 2.97% while the S&P 500 has fallen -0.11% as of 2:05 PM on Thursday, Sep 10. CGC is higher by $0.49 from the previous closing price of $16.36 on volume of 5,118,498 shares. Over the past year the S&P 500 has gained 13.14% while CGC has fallen -38.54%. CGC lost -$1.79 per share the over the last 12 months.

Click Here to get the full report on Canopy Growth Corp (CGC) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Is Global Cord Blood Corp (CO) Stock a Great Value?

Denali Therapeutics Inc (DNLI) Stock Climbs 10.58% This Week; Should You Buy?

Should Replimune Group Inc (REPL) Stock be in Your Portfolio?

Should You Buy AcelRx Pharmaceuticals Inc (ACRX) Stock?

Sector Update: Health Care Stocks Slipping in Late Trade

Related Companies